Handelsbanken Fonder’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-5,732
| Closed | -$584K | – | 1587 |
|
|
2023
Q2 | $584K | Sell |
5,732
-2,500
| -30% | -$255K | ﹤0.01% | 985 |
|
|
2023
Q1 | $748K | Buy |
8,232
+1,000
| +14% | +$90.9K | ﹤0.01% | 808 |
|
|
2022
Q4 | $275K | Buy |
+7,232
| New | +$275K | ﹤0.01% | 1295 |
|
|
2021
Q4 | – | Sell |
-5,900
| Closed | -$594K | – | 1771 |
|
|
2021
Q3 | $594K | Hold |
5,900
| – | – | ﹤0.01% | 1239 |
|
|
2021
Q2 | $835K | Buy |
5,900
+800
| +16% | +$113K | ﹤0.01% | 1027 |
|
|
2021
Q1 | $508K | Hold |
5,100
| – | – | ﹤0.01% | 1191 |
|
|
2020
Q4 | $630K | Sell |
5,100
-1,800
| -26% | -$222K | ﹤0.01% | 1033 |
|
|
2020
Q3 | $672K | Sell |
6,900
-20,000
| -74% | -$1.95M | ﹤0.01% | 858 |
|
|
2020
Q2 | $4.2M | Buy |
26,900
+12,900
| +92% | +$2.01M | 0.04% | 382 |
|
|
2020
Q1 | $2.02M | Sell |
14,000
-1,000
| -7% | -$144K | 0.04% | 164 |
|
|
2019
Q4 | $3.07M | Buy |
+15,000
| New | +$3.07M | 0.05% | 167 |
|